Meet us at BioEquity Europe 2025 in Bruges (BE)

Posted on : |

Dendrogenix CEO, CSO and CDO will attend to BioEquity Europe 2025 | May 12–14, 2025 | Bruges, Belgium. Celebrating its 25th year, BioEquity Europe is the destination event for biopharma decision-makers to network, partner and debate critical issues facing the biotech industry.

Tuesday October 22nd, 2024
Next
DENDROGENIX S.A.

Founded in 2018, Dendrogenix develop first-in-class molecules, Dendrogenins, to address high unmet medical needs in hearing loss and neurology.

© 2024 Dendrogenix